2PPZ - Header Asymmetric Unit

HEADER STRUCTURAL PROTEIN 01-MAY-07 2PPZ

TITLE NMR SOLUTION STRUCTURE OF THE VILLIN HEADPIECE MUTANT G34L

COMPND MOL_ID: 1; COMPND 2 MOLECULE: VILLIN-1; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: C-TERMINAL RESIDUES OF HEADPIECE DOMAIN, COMPND 5 SEQUENCE DATABASE RESIDUES 792-826; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES

SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 OTHER_DETAILS: SYNTHEZIZED ON A PEPTIDE SYNTHEZIZER USING SOURCE 4 THE FMOC/BUT STRATEGY. THE PEPTIDE IS NATURALLY FOUND IN SOURCE 5 GALLUS GALLUS (CHICKEN).

KEYWDS SMALL STABLE CORE, ALPHA HELICAL, THERMOSTABLE, IN SILICO KEYWDS 2 SEQUENCE OPTIMIZATION, STRUCTURAL PROTEIN

EXPDTA SOLUTION NMR

NUMMDL 10

AUTHOR W.GRONWALD,T.HOHM,D.HOFFMANN

REVDAT 2 11-MAR-08 2PPZ 1 JRNL VERSN REVDAT 1 29-MAY-07 2PPZ 0

JRNL AUTH W.GRONWALD,T.HOHM,D.HOFFMANN JRNL TITL EVOLUTIONARY PARETO-OPTIMIZATION OF STABLY FOLDING JRNL TITL 2 PEPTIDES JRNL REF BMC BIOINFORMATICS V. 9 109 2008 JRNL REFN ESSN 1471-2105 JRNL PMID 18284690 JRNL DOI 10.1186/1471-2105-9-109

REMARK 1

REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE.

REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CYANA 2.1 REMARK 3 AUTHORS : GUNTERT, MUMENTHALER AND WUTHRICH REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: TORSION ANGLE DYNAMICS

REMARK 4 REMARK 4 2PPZ COMPLIES WITH FORMAT V. 3.15, 01-DEC-08

REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 02-MAY-07. REMARK 100 THE RCSB ID CODE IS RCSB042656.

REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 5.0 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 4.3 MG PEPTIDE DISSOLVED IN REMARK 210 0.5 ML 90% H2O, 10% D2O (V/V) REMARK 210 AND 0.1 MM 2,2-DIMETHYL-2- REMARK 210 SILAPENTANE SULFONIC ACID REMARK 210 (DSS) FOR INTERNAL REFERENCING REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D TOCSY, 80 MS MIXING TIME, REMARK 210 2D NOESY, 250 MS MIXING TIME REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : AUREMOL 1.1, XWINNMR 3.2 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH FAVORABLE NON REMARK 210 -BOND ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL

REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS.

REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 THR A 14 103.27 -50.39 REMARK 500 1 LYS A 33 -68.36 -124.95 REMARK 500 1 LEU A 34 177.54 -56.14 REMARK 500 2 LEU A 2 113.79 -160.92 REMARK 500 2 THR A 14 103.18 -50.40 REMARK 500 2 LYS A 33 100.74 -175.46 REMARK 500 2 LEU A 34 -61.35 -169.71 REMARK 500 3 LEU A 2 113.18 -160.65 REMARK 500 3 THR A 14 103.40 -50.38 REMARK 500 3 LYS A 33 -72.97 -139.29 REMARK 500 3 LEU A 35 114.48 -164.39 REMARK 500 4 LEU A 2 109.84 -161.06 REMARK 500 4 THR A 14 104.01 -50.70 REMARK 500 4 LYS A 33 -74.07 -111.86 REMARK 500 5 THR A 14 104.24 -48.21 REMARK 500 5 LYS A 33 -68.43 -142.86 REMARK 500 5 LEU A 35 118.65 -166.95 REMARK 500 6 THR A 14 104.78 -47.73 REMARK 500 6 LYS A 33 -63.18 -133.00 REMARK 500 6 LEU A 34 179.80 -57.50 REMARK 500 7 THR A 14 104.20 -48.72 REMARK 500 8 THR A 14 102.99 -50.75 REMARK 500 8 LYS A 33 112.50 -179.03 REMARK 500 8 LEU A 34 -62.38 -170.17 REMARK 500 9 THR A 14 103.04 -50.83 REMARK 500 9 LYS A 33 -71.59 -108.72 REMARK 500 9 LEU A 35 85.16 60.47 REMARK 500 10 THR A 14 104.48 -48.05 REMARK 500 10 LYS A 33 110.50 -175.58 REMARK 500 10 LEU A 34 -62.25 -167.15 REMARK 500 REMARK 500 REMARK: NULL

REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 15245 RELATED DB: BMRB

REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE AUTHORS STATE THAT RESIDUE MET1 OF THE PEPTIDE IS NOT REMARK 999 FROM VILLIN BUT WAS INCLUDED TO COMPARE THEIR FRAGMENT WITH REMARK 999 THE CORRESPONDING STRUCTURE IN PDB ENTRY 1VII WHERE MET1 REMARK 999 IS ALSO INCLUDED.

DBREF 2PPZ A 2 36 UNP P02640 VILI_CHICK 792 826

SEQADV 2PPZ MET A 1 UNP P02640 SEE REMARK 999 SEQADV 2PPZ LEU A 34 UNP P02640 GLY 824 ENGINEERED

SEQRES 1 A 36 MET LEU SER ASP GLU ASP PHE LYS ALA VAL PHE GLY MET SEQRES 2 A 36 THR ARG SER ALA PHE ALA ASN LEU PRO LEU TRP LYS GLN SEQRES 3 A 36 GLN ASN LEU LYS LYS GLU LYS LEU LEU PHE

HELIX 1 1 SER A 3 GLY A 12 1 10 HELIX 2 2 THR A 14 ASN A 20 1 7 HELIX 3 3 PRO A 22 LEU A 34 1 13

CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1

ORIGX1 1.000000 0.000000 0.000000 0.00000

ORIGX2 0.000000 1.000000 0.000000 0.00000

ORIGX3 0.000000 0.000000 1.000000 0.00000

SCALE1 1.000000 0.000000 0.000000 0.00000

SCALE2 0.000000 1.000000 0.000000 0.00000

SCALE3 0.000000 0.000000 1.000000 0.00000